AIM Concept Integration
3rd Year MBBS
MULTISYSTEM
3rd Year MBBS
MULTISYSTEM
Topic 18 — Clinical Behavior, Spread, Diagnosis, Staging and Immunity of Tumors
A rapid integration of how malignant tumors affect the host, spread, are diagnosed and staged, and interact with anti-tumor immunity.
:contentReference[oaicite:0]{index=0}
1. THE TOPIC IN ONE CONNECTED FLOW
Malignant tumors cause disease through local growth, systemic effects and metastatic spread. Their biological behavior is assessed by morphology and extent of spread, while host immunity may recognize tumor antigens and limit tumor growth. Cancer progresses when malignant cells successfully invade, disseminate and escape effective immune control.
Tumor Growth
Increasing neoplastic cell mass and altered function
Increasing neoplastic cell mass and altered function
→
Host Effects
Compression, obstruction, tissue destruction, cachexia or paraneoplastic effects
Compression, obstruction, tissue destruction, cachexia or paraneoplastic effects
→
Local Invasion
Reduced adhesion → matrix degradation → stromal penetration
Reduced adhesion → matrix degradation → stromal penetration
→
Metastatic Spread
Lymphatic, hematogenous or body-cavity seeding
Lymphatic, hematogenous or body-cavity seeding
→
Diagnosis
Morphology supported by immunohistochemical, biochemical and molecular methods
Morphology supported by immunohistochemical, biochemical and molecular methods
→
Grade + Stage
Microscopic aggressiveness + anatomical extent
Microscopic aggressiveness + anatomical extent
→
Immune Balance
Recognition and killing versus immune evasion
Recognition and killing versus immune evasion
2. KEY CLINICAL CONNECTIONS
Cancer Cachexia
Tumor and host inflammatory mediators → increased protein and fat catabolism → loss of skeletal muscle and adipose tissue → weakness and progressive weight loss.
Paraneoplastic Manifestation
Tumor-derived hormone-like substance or immune reaction → systemic effect remote from the primary lesion → may reveal an otherwise occult malignancy.
Metastatic Pattern
Primary tumor → vascular or lymphatic entry → survival and exit at distant tissue → metastatic deposit; successful colonization occurs in only a fraction of disseminated cells.
Diagnosis and Extent
Tissue architecture and cellular morphology → tumor identification; ancillary tests refine classification → staging determines anatomical spread and major prognostic significance.
3. AIM HIGH-YIELD INTEGRATION REVIEW
⭐ Local effect → clinical feature:
Tumor compression, obstruction or tissue destruction explains many symptoms before metastasis occurs.
Tumor compression, obstruction or tissue destruction explains many symptoms before metastasis occurs.
⭐ Cachexia → metabolic wasting:
Cytokine-driven catabolism causes loss of muscle and fat, so nutritional support alone may not completely reverse the wasting.
Cytokine-driven catabolism causes loss of muscle and fat, so nutritional support alone may not completely reverse the wasting.
Paraneoplastic syndrome → remote tumor effect:
A systemic syndrome caused by tumor-derived substances or immune mechanisms is not explained by direct invasion or metastasis.
A systemic syndrome caused by tumor-derived substances or immune mechanisms is not explained by direct invasion or metastasis.
Invasion → metastasis:
Detachment, matrix penetration and migration permit malignant cells to enter vessels or body cavities and establish secondary deposits.
Detachment, matrix penetration and migration permit malignant cells to enter vessels or body cavities and establish secondary deposits.
Morphology → diagnosis:
Histopathology demonstrates tissue architecture and invasion, while immunohistochemistry and molecular testing help classify difficult tumors.
Histopathology demonstrates tissue architecture and invasion, while immunohistochemistry and molecular testing help classify difficult tumors.
⭐ Grade versus stage:
Grade reflects differentiation and microscopic aggressiveness; stage reflects the anatomical extent of disease and generally has greater prognostic importance.
Grade reflects differentiation and microscopic aggressiveness; stage reflects the anatomical extent of disease and generally has greater prognostic importance.
Tumor antigen → immune attack:
Cytotoxic T cells, natural killer cells, macrophages and antibodies can participate in recognition and destruction of malignant cells.
Cytotoxic T cells, natural killer cells, macrophages and antibodies can participate in recognition and destruction of malignant cells.
⭐ Immune pressure → tumor escape:
Antigen loss, reduced presentation and inhibitory signals allow less immunogenic or immune-resistant clones to survive and expand.
Antigen loss, reduced presentation and inhibitory signals allow less immunogenic or immune-resistant clones to survive and expand.
AIM Exam Trap:
Do not confuse grade with stage: a well-differentiated tumor may still have advanced nodal or distant spread.
Do not confuse grade with stage: a well-differentiated tumor may still have advanced nodal or distant spread.